Efficacy News and Research

RSS
IQWiG examines added benefit of belimumab for patients with systemic lupus erythematosus

IQWiG examines added benefit of belimumab for patients with systemic lupus erythematosus

CCE, Accretive Health partner to develop novel oncology care management

CCE, Accretive Health partner to develop novel oncology care management

Collegium commences enrollment in Oxycodone DETERx Phase 3 study in chronic lower back pain

Collegium commences enrollment in Oxycodone DETERx Phase 3 study in chronic lower back pain

Israel's Ministry of Health approves Medgenics’ INFRADURE Phase I/II clinical trials for hepatitis C

Israel's Ministry of Health approves Medgenics’ INFRADURE Phase I/II clinical trials for hepatitis C

Lilly decides to terminate pomaglumetad methionil Phase III trial on schizophrenia

Lilly decides to terminate pomaglumetad methionil Phase III trial on schizophrenia

Elan commences ELND005 Phase 2 study in Bipolar I Disorder

Elan commences ELND005 Phase 2 study in Bipolar I Disorder

FDA grants orphan designation to Aerial BioPharma’s ARL-N05 for treatment of narcolepsy

FDA grants orphan designation to Aerial BioPharma’s ARL-N05 for treatment of narcolepsy

Novartis receives FDA approval for Afinitor Disperz to treat subependymal giant cell astrocytoma

Novartis receives FDA approval for Afinitor Disperz to treat subependymal giant cell astrocytoma

PROTECT: Still no clear winner in the battle of the stent generations

PROTECT: Still no clear winner in the battle of the stent generations

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

Preventing falls in older people: an interview with Professor Lindy Clemson

Preventing falls in older people: an interview with Professor Lindy Clemson

Top-line results from Rexahn’s Archexin Phase II study on metastatic pancreatic cancer

Top-line results from Rexahn’s Archexin Phase II study on metastatic pancreatic cancer

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

Altheus Therapeutics initiates enrollment in Zoenasa Phase 2 study for ulcerative colitis

Altheus Therapeutics initiates enrollment in Zoenasa Phase 2 study for ulcerative colitis

Herceptin® (trastuzumab) delivery methods: an interview with Dr Gustavo Ismael

Herceptin® (trastuzumab) delivery methods: an interview with Dr Gustavo Ismael

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Nicotinamide may combat antibiotic-resistance staph infections

Nicotinamide may combat antibiotic-resistance staph infections

Personalized antiplatelet treatment leads to better outcomes in patients undergoing PCI

Personalized antiplatelet treatment leads to better outcomes in patients undergoing PCI

Morphotek commences MORAb-004 Phase II metastatic soft tissue sarcoma trial

Morphotek commences MORAb-004 Phase II metastatic soft tissue sarcoma trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.